{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:05:54Z","timestamp":1785679554617,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":8320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1038\/modpathol.3880077","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T12:57:28Z","timestamp":1081947448000},"page":"452-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Immunoreactivity of MIC2 (CD99) in Acute Myelogenous Leukemia and Related Diseases"],"prefix":"10.1016","volume":"13","author":[{"given":"Paul J","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Barcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleton C","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie W","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Sait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3880077_bib1","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1073\/pnas.76.12.6552","article-title":"A human thymus leukemia antigen defined by hybridoma monoclonal antibodies","volume":"76","author":"Levy","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/modpathol.3880077_bib2","first-page":"336","article-title":"Biochemical and genetic characterization of the HBA 71 Ewing's sarcoma cell surface antigen","volume":"51","author":"Fellinger","year":"1991","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3880077_bib3","first-page":"6127","article-title":"Characterization of a human endocrine tissue and tissue-associated Ewing's sarcoma antigen","volume":"48","author":"Hamilton","year":"1988","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.3880077_bib4","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1002\/j.1460-2075.1989.tb08485.x","article-title":"The E2 antigen, 32kDa glycoprotein involved in T-cell adhesion processes, is the Mic2 gene product","volume":"8","author":"Genlin","year":"1989","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.3880077_bib5","first-page":"231","article-title":"CD99 (p30\/32 MIC2) neuroectodermal\/Ewing's sarcoma antigen as an immunohistochemical marker: review of more than 600 tumors and the literature experience","volume":"2","author":"Stevenson","year":"1994","journal-title":"Appl Immunohistochem"},{"key":"10.1038\/modpathol.3880077_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00000478-199405000-00008","article-title":"Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30\/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma","volume":"18","author":"Weidner","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.3880077_bib7","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/00000478-199208000-00002","article-title":"Comparison of cell surface antigen HBA71 (p3\/32MIC2), neuron-specific enolase and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone","volume":"16","author":"Fellinger","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.3880077_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0046-8177(94)90203-8","article-title":"Ewing's sarcoma-routine diagnostic utilization of MIC2 analysis: a pediatric oncology group\/children's cancer group intergroup study","volume":"25","author":"Perlman","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3880077_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2559.1993.tb01243.x","article-title":"Immunocytochemical study of 12E7 in small round-cell tumours of childhood: an assessment of its sensitivity and specificity","volume":"23","author":"Ramani","year":"1993","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3880077_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0046-8177(94)90149-X","article-title":"MIC2 analysis in pediatric lymphomas and leukemias","volume":"25","author":"Riopel","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3880077_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0046-8177(97)90254-9","article-title":"MIC2, TdT, and CD34 expression in paraffin-embedded high-grade lymphoma\/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities","volume":"28","author":"Soslow","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.3880077_bib12","first-page":"250","article-title":"O13 (CD99) in spindle cell tumors: reactivity with hemangiopericytoma, solitary fibrous tumor, synovial sarcoma, and meningioma but rarely with sarcomatoid mesothelioma","volume":"3","author":"Renshaw","year":"1995","journal-title":"Appl Immunohistochem"},{"key":"10.1038\/modpathol.3880077_bib13","first-page":"227","article-title":"O13 (CD99) positivity in hematologic proliferations correlates with TdT positivity","volume":"10","author":"Robertson","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.3880077_bib14","first-page":"198","article-title":"Immunohistochemical assessment of MIC2 gene product in granulocytic sarcoma using six epitope retrieval system","volume":"3","author":"Cooper","year":"1995","journal-title":"Appl Immunohistochem"},{"key":"10.1038\/modpathol.3880077_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000206072","article-title":"Incidence of TdT positivity in cases of leukemia and lymphoma","volume":"75","author":"Drexler","year":"1986","journal-title":"Acta Haematol"},{"key":"10.1038\/modpathol.3880077_bib16","first-page":"1142","article-title":"Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia","volume":"7","author":"Drexler","year":"1993","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.3880077_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hon.2900070208","article-title":"Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapy","volume":"7","author":"Lo Coco","year":"1989","journal-title":"Hematol Oncol"},{"key":"10.1038\/modpathol.3880077_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2141.1988.tb07625.x","article-title":"Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia","volume":"69","author":"Parreira","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.3880077_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ajh.2830230103","article-title":"TdT activity in acute myeloid leukemia defined by monoclonal antibodies","volume":"23","author":"San Miguel","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.3880077_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00043426-198224000-00011","article-title":"Granulocytic sarcoma of the clavicle","volume":"4","author":"Miller","year":"1982","journal-title":"Am J Ped Hematol Oncol"},{"key":"10.1038\/modpathol.3880077_bib21","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/1097-0142(19861215)58:12<2697::AID-CNCR2820581225>3.0.CO;2-R","article-title":"Granulocytic sarcoma in nonleukemic patients","volume":"58","author":"Meis","year":"1986","journal-title":"Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3880077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3880077","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222040583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222040583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3880077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:15:57Z","timestamp":1760231757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222040583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S0893395222040583"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3880077","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoreactivity of MIC2 (CD99) in Acute Myelogenous Leukemia and Related Diseases","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3880077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2000 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}